The role of oral antiplatelet agents in atherothrombotic disease
about
Future innovations in anti-platelet therapies.Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.Individual variability of response and non-response to acetyl salicylic acid after cardiac surgery.ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
P2860
The role of oral antiplatelet agents in atherothrombotic disease
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The role of oral antiplatelet agents in atherothrombotic disease
@ast
The role of oral antiplatelet agents in atherothrombotic disease
@en
The role of oral antiplatelet agents in atherothrombotic disease
@nl
type
label
The role of oral antiplatelet agents in atherothrombotic disease
@ast
The role of oral antiplatelet agents in atherothrombotic disease
@en
The role of oral antiplatelet agents in atherothrombotic disease
@nl
prefLabel
The role of oral antiplatelet agents in atherothrombotic disease
@ast
The role of oral antiplatelet agents in atherothrombotic disease
@en
The role of oral antiplatelet agents in atherothrombotic disease
@nl
P2860
P1476
The role of oral antiplatelet agents in atherothrombotic disease
@en
P2093
James J Ferguson
P2860
P304
P356
10.2165/00129784-200606030-00002
P407
P577
2006-01-01T00:00:00Z
P6179
1032070741